Research outputs

Our people

Filter research outputs

What type of research output do you want to show?

All

Conference Paper

Journal

2025

Contributors to organ damage in childhood lupus: corticosteroid use and disease activity.

Hanif, M., Sarker, C., Al-Abadi, E., Armon, K., Bailey, K., Bohm, M., . . . Smith, E. M. D. (2025). Contributors to organ damage in childhood lupus: corticosteroid use and disease activity.. Rheumatology (Oxford, England), 64(5), 3028-3038. doi:10.1093/rheumatology/keae592

DOI: 10.1093/rheumatology/keae592
: Journal article

Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.

Stott, K. E., Tembo, D., Kajanga, C., Ahmadu, A., Namakhwa, D., Kolamunnage-Dona, R., . . . AMBITION Study Group . (2025). Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal Meningitis.. Open forum infectious diseases, 12(4), ofaf190. doi:10.1093/ofid/ofaf190

DOI: 10.1093/ofid/ofaf190
: Journal article

2024

OP0246 FACTORS ASSOCIATED WITH DAMAGE ACCRUAL IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): CORTICOSTEROID REGIMENS AND MAINTENANCE OF LOW DISEASE ACTIVITY

Hanif, M., Sarker, C., Beresford, M. W., & MD Smith, E. (2024). OP0246 FACTORS ASSOCIATED WITH DAMAGE ACCRUAL IN CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE): CORTICOSTEROID REGIMENS AND MAINTENANCE OF LOW DISEASE ACTIVITY. In Annals of the Rheumatic Diseases Vol. 83 (pp. 227-228). Elsevier BV. doi:10.1136/annrheumdis-2024-eular.1166

DOI: 10.1136/annrheumdis-2024-eular.1166
: Conference Paper

OP0277 EVALUATING THE IMPACT OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS T2T TARGET ATTAINMENT: MITIGATING FLARES AND NEW DAMAGE ACCRUAL

Sarker, C., Jorgensen, A. L., Beresford, M. W., & MD Smith, E. (2024). OP0277 EVALUATING THE IMPACT OF CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS T2T TARGET ATTAINMENT: MITIGATING FLARES AND NEW DAMAGE ACCRUAL. In Annals of the Rheumatic Diseases Vol. 83 (pp. 229). Elsevier BV. doi:10.1136/annrheumdis-2024-eular.697

DOI: 10.1136/annrheumdis-2024-eular.697
: Conference Paper

POS0173 EVALUATING CHILDHOOD LUPUS LOW DISEASE ACTIVITY STATE (cLLDAS) AS A POTENTIAL TREAT-TO-TARGET TREATMENT ENDPOINT: A VALIDATION AND SENSITIVITY ANALYSIS

Smith, E. M., Sarker, C., Jorgensen, A. L., & Beresford, M. W. (2024). POS0173 EVALUATING CHILDHOOD LUPUS LOW DISEASE ACTIVITY STATE (cLLDAS) AS A POTENTIAL TREAT-TO-TARGET TREATMENT ENDPOINT: A VALIDATION AND SENSITIVITY ANALYSIS. In Annals of the Rheumatic Diseases Vol. 83 (pp. 529). Elsevier BV. doi:10.1136/annrheumdis-2024-eular.5896

DOI: 10.1136/annrheumdis-2024-eular.5896
: Conference Paper